Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market...
Keep Reading →
December 16 - Hedge Funds, News
In this article we will take a look at whether hedge funds think PDL BioPharma Inc. (NASDAQ:PDLI) is a good investment right now.
Keep Reading →
June 27 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
December 10 - Hedge Funds, News
Is PDL BioPharma Inc. (NASDAQ:PDLI) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock.
Keep Reading →
October 31 - Hedge Funds, News
Hedge funds are not perfect. They have their bad picks just like everyone else.
Keep Reading →
June 20 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Keep Reading →
May 12 - Hedge Funds, News
Like everyone else, elite investors make mistakes.
Keep Reading →
December 23 - Hedge Funds, News
Here’s a breakdown on how the Magic Formula Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns six stocks and is 60% invested.
The return on the invested capital is 5.
Keep Reading →
December 9 - News, Stock Analysis
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Keep Reading →
December 2 - Hedge Funds, News
Here’s a breakdown on how the Enterprising Investor Portfolio is performing.
Since beginning this Shadow Stock Portfolio on June 1, 2016, it owns two stocks and is 20% invested.
The return on the invested capital is -0.90%.
Keep Reading →
November 11 - News, Stock Analysis
We, at Insider Monkey, have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
Keep Reading →
November 25 - Hedge Funds, News
One of the funds we track is Joel Greenblatt's Gotham Asset Management, which recently filed its 13F form, disclosing its equity portfolio as at the end of the third quarter ...
Keep Reading →
November 15 - Hedge Funds, News
Editor's Note: Vringo, Inc. (NASDAQ:VRNG), Google Inc (NASDAQ:GOOG), AOL, Inc.
Keep Reading →
September 6 - News
If you were to ask many market players, hedge funds are assumed to be overrated, old investment vehicles of a forgotten age.
Keep Reading →
September 4 - News
In the eyes of many market players, hedge funds are seen as overrated, old investment tools of a period lost to current times.
Keep Reading →
September 3 - News
In today’s marketplace, there are dozens of methods market participants can use to watch the equity markets.
Keep Reading →
September 3 - News
In the financial world, there are a multitude of gauges investors can use to watch publicly traded companies. A couple of the best are hedge fund and insider trading interest.
Keep Reading →
August 30 - News
In the 21st century investor’s toolkit, there are dozens of metrics investors can use to track Mr. Market.
Keep Reading →
August 22 - News
MannKind Corporation (NASDAQ:MNKD) has gotten one of the biggest votes of confidence we've seen from the smart money, out of the entire stock market universe and the 500+ elite...
Keep Reading →
August 22 - News
The biotech industry is known for fast paced acquisitions and rapid market consolidation.
Keep Reading →
July 29 - News
When screening for health-care dividend stocks, it's tempting to look for the ones with the highest yield.
Keep Reading →
July 5 - News
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Keep Reading →
June 21 - News
According to most stock holders, hedge funds are viewed as underperforming, old financial vehicles of the past.
Keep Reading →
June 14 - News
In the eyes of most traders, hedge funds are seen as worthless, old financial tools of the past.
Keep Reading →
June 10 - News
In the financial world, there are plenty of indicators market participants can use to track publicly traded companies.
Keep Reading →
June 6 - News
This article is removed because of technical problems
Keep Reading →
June 4 - News
At the moment, there are a multitude of indicators market participants can use to track their holdings.
Keep Reading →
June 4 - News
If you'd ask most shareholders, hedge funds are assumed to be underperforming, old investment tools of the past.
Keep Reading →
June 3 - News
Keeping a close eye on two particular classes of investors can tell you a lot about how stocks might move in the future.
Keep Reading →
May 23 - News
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Keep Reading →
May 15 - News
As part of the split, the pharmaceutical company looks poised to turn its current drug-marketing joint venture with London-based GlaxoSmithKline plc (ADR) (NYSE:GSK) into an...
Keep Reading →
May 15 - News
Following in the footsteps of Abbott Laboratories (NYSE:ABT) spinning out its drug division into AbbVie Inc (NYSE:ABBV), and Pfizer spinning out its animal health division into...
Keep Reading →
April 26 - News
MannKind Corporation (NASDAQ:MNKD) was in 8 hedge funds' portfolio at the end of December. MNKD shareholders have witnessed an increase in hedge fund interest of late.
Keep Reading →
April 13 - News
In the 21st century investor’s toolkit, there are a multitude of indicators investors can use to track publicly traded companies.
Keep Reading →
April 2 - News
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield.
Keep Reading →
March 14 - News
Dividend investing is popular again.
Keep Reading →
March 8 - News
Elan Corporation, plc (ADR) (NYSE:ELN) was nice enough to give us a little more detail on what it plans to do with the $3.25 million that the biotech stands to get from Biogen...
Keep Reading →
February 25 - News